The potential for liquid biopsies in the precision medical treatment of breast cancer
Currently the clinical management of breast cancer relies on relatively few prognostic/predictive clinical markers (estrogen receptor, progesterone receptor, HER2), based on primary tumor biology. Circulating biomarkers, such as circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs) may enh...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
China Anti-Cancer Association
2016-03-01
|
| Colecção: | Cancer Biology & Medicine |
| Assuntos: | |
| Acesso em linha: | http://www.cancerbiomed.org/index.php/cocr/article/view/906 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|